Objective Visual Quality Analysis System is Used in Cataract
Launched by WUHAN UNION HOSPITAL, CHINA · Feb 13, 2021
Trial Information
Current as of June 26, 2025
Unknown status
Keywords
ClinConnect Summary
The Objective Visual Quality Analysis System (OQAS) is a new inspection technology used to objectively assess the visual quality of the human eye. It can detect the impact of ocular refractive system diseases on the objective visual quality of patients. It is currently mainly used to assess the progress of cataracts and help selection the timing of surgery has achieved good clinical results. Before the emergence of OQAS, the rating of cataracts largely relied on the subjective experience of physicians, and OQAS could accurately assess the effects of cataracts on the visual quality of the hu...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Cataract patients aged 18-90 or patients after cataract surgery;
- • 2. Signed and dated informed consent;
- • 3. Commit to abide by the research procedures and cooperate with the implementation of the whole process research
- Exclusion Criteria:
- • 1. Obvious conjunctivitis;
- • 2. Obvious corneal epithelial punctate staining, corneal epithelial shedding;
- • 3. Keratitis;
- • 4. Uveitis;
- • 5. Corneal scar;
- • 6. Severe vitreous opacity or hemorrhage;
- • 7. Other situations deemed unsuitable for inclusion in this study after evaluation by ophthalmologists.
About Wuhan Union Hospital, China
Wuhan Union Hospital, affiliated with Huazhong University of Science and Technology, is a leading medical institution located in Wuhan, China. Renowned for its comprehensive healthcare services and advanced research capabilities, the hospital plays a pivotal role in clinical trials aimed at enhancing medical knowledge and patient care. With a commitment to innovation and excellence, Wuhan Union Hospital collaborates with various stakeholders to conduct rigorous and ethically sound clinical research, contributing significantly to the advancement of medical science and public health both domestically and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Wuhan, Hubei, China
Patients applied
Trial Officials
yukan huang, professor
Study Chair
Wuhan Union Hospital, China
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials